Cornelis Boersma

14PUBLICATIONS
32CO-AUTHORS
Immunogenetics (incl. genetic immunology)Epidemiological modellingNeonatologyPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 26, 2026
Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands.

|Jul 12, 2025
Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands.

Bart P H Slob, Maarten J Postma, Maaike Weersma

|May 09, 2025
Prerequisites for Cost-Effective Home Blood Pressure Telemonitoring: Early Health Economic Analysis.

Job van Steenkiste, Pim van Dorst, Daan Dohmen

|Feb 20, 2025
Cost-Effectiveness Analysis of Nirsevimab for Preventing Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease in Dutch Infants: An Analysis Including All-Infant Protection.

Florian Zeevat, Simon van der Pol, Alexia Kieffer

|Oct 11, 2024
Advancing the role of real-world evidence in comparative effectiveness research.

Monica Daigl, Seye Abogunrin, Felipe Castro

|Aug 30, 2024
Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade.

Lotte Westerink, Sharon Wolters, Guiling Zhou

Pageof 3

Frequent Collaborators

10 joint publications

Maarten Postma

3 joint publications

Jan Wilschut

3 joint publications

Tjalke Westra

3 joint publications

Joost Simons